CN1079241C - Chinese patent drug for curing cough and asthma - Google Patents
Chinese patent drug for curing cough and asthma Download PDFInfo
- Publication number
- CN1079241C CN1079241C CN97106168A CN97106168A CN1079241C CN 1079241 C CN1079241 C CN 1079241C CN 97106168 A CN97106168 A CN 97106168A CN 97106168 A CN97106168 A CN 97106168A CN 1079241 C CN1079241 C CN 1079241C
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese patent
- medicine
- parts
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a Chinese patent medicine for curing chronic bronchitis and bronchial asthma, namely isoprenaline. The medicine is prepared by processing the raw materials of datura flower, earth worm, processed pinellia tuber, ophiopogon tuber, Chinese date, Chinese yam, red sage root and licorice root. The present invention has the advantages of unique prescription and significant therapeutic effect without toxic or side effect.
Description
The present invention relates to a kind of medicine for the treatment of chronic bronchitis and bronchial asthma, specifically is that feedstock production forms treatment cough illness Chinese patent medicine with the Chinese herbal medicine.
Chronic bronchitis and bronchial asthma are a kind of intractable respiratory system diseases, and particularly the dried cold regional sickness rate in the north is very high in China.Doctor trained in Western medicine adopts symptomatic treatment more at present, and injection penicillin and anti-inflammatory type medicine or hormone medicine side effect such as edema often occur, and drug withdrawal are recurred promptly.And the prescription medication of the traditional Chinese medical science is controlled for debating disease executing, no fixed drug, and mostly be decoction, and take inconvenience, therapeutic effect is not remarkable yet.
The object of the present invention is to provide a kind of antiinflammatory Zhichuan rapidly and the treatment chronic bronchitis that has no side effect and the treatment cough illness Chinese patent medicine of bronchial asthma.
Solution of the present invention is based on motherland's medical science to chronic bronchitis and pathogenetic understanding of bronchial asthma and Therapeutic Principle, select relieving cough and asthma, strengthening spleen, tonifying kidney lung and middle QI invigorating, blood-activating stasis-removing kind Chinese medicine for use with reference to the modern pharmacological research achievement, make its effect that suppresses respiratory tract glandular secretion, vasodilator, enhancing total serum protein, reach the purpose of inflammation-diminishing and cough-controlling.
It is to be made by the following weight proportion raw material that the present invention treats the cough illness Chinese patent medicine:
Flos Daturae 5-12 part Pheretima 5-20 part Rhizoma Pinelliae Preparatum 8-14 part 8-15 Radix Ophiopogonis part
Fructus Jujubae 5-30 part Rhizoma Dioscoreae 7-14 part Radix Salviae Miltiorrhizae 4-20 part Radix Glycyrrhizae 4-8 part
Treatment cough illness Chinese patent medicine of the present invention, wherein the weight proportion of each raw material is:
Flos Daturae 8-12 part Pheretima 8-12 part Rhizoma Pinelliae Preparatum 10-14 part
Radix Ophiopogonis 10-14 part Fructus Jujubae 10-14 part Rhizoma Dioscoreae 10-14 part
Radix Salviae Miltiorrhizae 4-8 part Radix Glycyrrhizae 6-8 part
Treatment cough illness Chinese patent medicine optimum weight proportioning of the present invention is:
6 parts in 6 portions of Radix Glycyrrhizaes of 10 parts of Rhizoma Pinelliae Preparatum of 10 parts of Pheretimas of Flos Daturae, 12 parts of Radix Salviae Miltiorrhizaes of 12 portions of Rhizoma Dioscoreaes of 12 portions of Fructus Jujubaes, 12 parts of Radix Ophiopogonis
After the present invention adopted above scheme, treatment chronic bronchitis and bronchial asthma were evident in efficacy, and effective percentage reaches 100%, and cure rate is up to 87%, and it is rapid to remove " cough with asthma " symptom, has no side effect taking convenience.
Among the present invention, Flos Daturae, hot, warm, go into the spleen lung meridian, spasmolytic, dispelling cold and dampness, lung qi dispersing gas, relieving cough and asthma; Pheretima, salty-cold, the spasmolytic of relievining asthma collateral dredging; The Rhizoma Pinelliae, Xin Wen, drying dampness to eliminate phlegm and middle sending down the abnormal ascending QI; Radix Ophiopogonis, sweet flat being slightly cold, nourishing the stomach to promote the production of body fluid had both been made the medicine-feeding warm-dryness syndrome, again nourishing the lung to arrest cough.(abovely all see " Chinese medicine " the 198th page, 197 pages, 188 pages, 222 pages, the new medical college in Jiangsu is compiled, and the Jiangsu People's Press published in 1973) modern pharmacological research proves: the Main Ingredients and Appearance of Flos Daturae is: scopolamine, hyoscyamine and atropine; (see " clinical medicine handbook " the 282nd page, Nanjing Medical College, No.1 Affiliated Hospital, Nanjing Medical College compile, and Shanghai science tech publishing house published in 1988) cholinolytic effect is arranged, can suppress the respiratory tract glandular secretion, thereby the maintenance respiratory passage unblocked plays spasmolytic and phlegm-dispelling functions.Pheretima has the effect of antihistaminic, diastole vigour of style pipe; According to national exhibition material: with Pheretima injection for treating bronchial asthma, eczema and urticaria all effectively " see " Chinese medicine " the 197th page).Rhizoma Pinelliae Main Ingredients and Appearance contains B-sterin glycoside and free acid, alkaloid etc., is the key medicine of eliminating the phlegm.(see " Chinese medicine voluminous dictionary " the 775th page.The new medical college in Jiangsu is compiled, and Shanghai science tech publishing house published in 1985).Contain the volume glucose Radix Ophiopogonis, phlegmatic temperament, materials such as a small amount of B-sitosterol and vitamin A; Relieving cough and expelling phlegm heart tonifying diuresis is arranged; To Staphylococcus albus, escherichia coli have antibacterial action (seeing " Chinese medicine voluminous dictionary " 1024 pages) to Radix Ophiopogonis powder external.It is that fraud is mended in correction that four medicines share, and complements each other, wherein suitable.Other join Fructus Jujubae, Rhizoma Dioscoreae strengthening the spleen and tonifying the lung kidney and in.Fructus Jujubae contains how sharp protein, saccharide, organic acid, vitamin A, B, C, and micro-calcium, phosphorus, ferrum have the total serum protein of increasing and albuminous effect (seeing " Chinese medicine voluminous dictionary " the 101st page).Rhizoma Dioscoreae contains Saponin, phlegmatic temperament, choline, starch, protein, and free amino acid, vitamin C etc. are nourishing key medicine (seeing " Chinese medicine voluminous dictionary " the 166th page).Radix Glycyrrhizae and middle QI invigorating relieving cough and resolving phlegm.The person that uses the Radix Salviae Miltiorrhizae, be because of chronic bronchitis and bronchial asthma patient, the polyphyly medical history is longer, principle according to " prolonged illness must the stasis of blood ", must give blood circulation promoting and blood stasis dispelling, report according to pharmacological research: Radix Salviae Miltiorrhizae contains the luxuriant and rich with fragrance a kind of jade class of furo pigment TANSHINONES, vitamin E, and is beneficial to cardiovascular, but the little blood vessel of diastole tip (seeing " Chinese medicine voluminous dictionary " 478 pages).With the collateral dredging function of Pheretima, the heart tonifying diuresis function of Radix Ophiopogonis plays cardiac function enhancing jointly, improves sanguimotor effect.All medicines share, hot sweet cold expelling dampness, lowering the adverse-rising QI to resolve phlegm, salty-cold antiallergic is relievingd asthma, sweet flat reinforcing spleen and kidney and in, the cough-relieving of promoting the production of body fluid; The hardship blood circulation promoting and blood stasis dispelling that is slightly cold improves cardiac function, strengthens the body's natural resistance.Thereby reach eliminating pathogenic factor for supporting vital QI, the purpose of vital QI recovered after pathogens eliminated.
For showing the therapeutic effect of medicine of the present invention to chronic bronchitis and bronchial asthma, the present invention is through the clinical observation of 143 routine systems, and get medical history, patient's 57 examples that the state of an illness is suitable are organized in contrast, adopt conventional western medicine therapy; Get 86 examples as test group, take medicine secondary every day of the present invention, each 3 grams, the observation period is four months.
Adopt identical standard to add up at last, criterion of therapeutical effect is:
(1) symptom after taking medicine alleviates immediately or disappears and is considered as effectively;
(2) sx still need continue the pill taker and is considered as not healing;
(3) drug withdrawal after 1 year not the recidivist be complete more;
Table 1 matched group curative effect situation
Table 2 test group curative effect situation
Below in conjunction with embodiment the present invention is described in detail.
Embodiment 1, gets Flos Daturae 10g, Pheretima 10g, Rhizoma Pinelliae Preparatum 12g, Radix Ophiopogonis 12g, Fructus Jujubae 12g, Rhizoma Dioscoreae 12g, Radix Glycyrrhizae 6g, Radix Salviae Miltiorrhizae 6g, goes clean mixing, dry in the sun is to the utmost point dried repeatedly, is ground into fine-powdered powder more jointly, and is encapsulated or be rolled into tablet, each 0.5g can make medicine of the present invention.Oral every day 2 times, each 5-6 grain/sheet got final product in three months.
Embodiment 2, get Flos Daturae 5g, and Pheretima 5g, Rhizoma Pinelliae Preparatum 8g, Radix Ophiopogonis, 15g, Fructus Jujubae 30g, Rhizoma Dioscoreae 14g, Radix Salviae Miltiorrhizae 20g, Radix Glycyrrhizae 4g mixed dry in the sun to the utmost point in get final product, cured mainly chronic bronchitis merging emphysema, pulmonary heart disease person.
Embodiment 3, get Flos Daturae 12g, Pheretima 12g, Rhizoma Pinelliae Preparatum 14g, Radix Ophiopogonis 15g, Fructus Jujubae 10g, Rhizoma Dioscoreae 10g, Radix Salviae Miltiorrhizae 20g, Radix Glycyrrhizae 8g, and method cures mainly the bronchial asthma that causes because of allergy with embodiment 1.
Claims (3)
1, a kind of treatment cough illness Chinese patent medicine is characterized in that it is the medicament of being made by the following weight proportion raw material: Flos Daturae 5-12 part Pheretima 5-20 part Rhizoma Pinelliae Preparatum 8-14 part 8-15 Radix Ophiopogonis part Fructus Jujubae 5-30 part Rhizoma Dioscoreae 7-14 part Radix Salviae Miltiorrhizae 4-20 part Radix Glycyrrhizae 4-8 part.
2, treatment cough illness Chinese patent medicine according to claim 1, wherein the weight proportion of each raw material is: Flos Daturae 8-12 part Pheretima 8-12 part Rhizoma Pinelliae Preparatum 10-14 part 10-14 Radix Ophiopogonis part Fructus Jujubae 10-14 part Rhizoma Dioscoreae 10-14 part Radix Salviae Miltiorrhizae 4-8 part Radix Glycyrrhizae 6-8 part.
3, treatment cough illness Chinese patent medicine according to claim 1, wherein the weight proportion of each raw material is: 6 parts in 6 portions of Radix Glycyrrhizaes of 10 parts of Rhizoma Pinelliae Preparatum of 10 parts of Pheretimas of Flos Daturae, 12 parts of Radix Salviae Miltiorrhizaes of 12 portions of Rhizoma Dioscoreaes of 12 portions of Fructus Jujubaes, 12 parts of Radix Ophiopogonis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97106168A CN1079241C (en) | 1997-10-28 | 1997-10-28 | Chinese patent drug for curing cough and asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97106168A CN1079241C (en) | 1997-10-28 | 1997-10-28 | Chinese patent drug for curing cough and asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1203797A CN1203797A (en) | 1999-01-06 |
| CN1079241C true CN1079241C (en) | 2002-02-20 |
Family
ID=5168434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97106168A Expired - Fee Related CN1079241C (en) | 1997-10-28 | 1997-10-28 | Chinese patent drug for curing cough and asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1079241C (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103595A (en) * | 1994-06-14 | 1995-06-14 | 魏新华 | Dispensation and preparation process of respiratory immune tablets |
| CN1140087A (en) * | 1996-06-11 | 1997-01-15 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
-
1997
- 1997-10-28 CN CN97106168A patent/CN1079241C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103595A (en) * | 1994-06-14 | 1995-06-14 | 魏新华 | Dispensation and preparation process of respiratory immune tablets |
| CN1140087A (en) * | 1996-06-11 | 1997-01-15 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1203797A (en) | 1999-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102284022A (en) | Cough medicament and preparation method thereof | |
| CN101869678A (en) | Medicament for treating bronchitis cough | |
| CN101041046A (en) | Chinese traditional medicine compound took orally for treating morning diarrhea | |
| CN101485834B (en) | Chinese medicine for treating diabetes | |
| CN101041049A (en) | Chinese traditional medicine compound took orally for treating chronic bronchitis | |
| CN105748900A (en) | Traditional Chinese medicine for treating chronic laryngitis and preparation method of traditional Chinese medicine | |
| CN101032598B (en) | Expectorant cough suppressant and anti-asthmatic healthy wine | |
| CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
| CN106692909A (en) | Pyrus pyrifolia tree viscum coloratum grease with lung-clearing and phlegm-eliminating effects | |
| CN1085090C (en) | Medicine for stopping cough | |
| CN1079241C (en) | Chinese patent drug for curing cough and asthma | |
| CN1077896A (en) | Medicine for psoriasis and manufacture method | |
| CN104824212A (en) | Platycodon grandiflorum and liquorice life-preserving traditional Chinese medicine tea beverage and preparation method | |
| CN100389802C (en) | Medicine for treating and preventing chronic obstractive pneumonia | |
| CN1634288A (en) | Pure Chinese herbal medicine pillow for preventing and treating repeated infection of the respiratory tract and preparation technique thereof | |
| CN1232682A (en) | Chinese medicine for curing malignant tumor and its preparation | |
| CN100391530C (en) | Medicine for treating nephrosis syndrome | |
| CN102380017A (en) | Medicament for treating diabetes and preparation method of medicament | |
| CN108704064A (en) | A kind of Chinese medicine composition and preparation method for treating AIDS | |
| CN102048154A (en) | Health protection food having function of regulating blood sugar and preparation method thereof | |
| CN1314160A (en) | Oral pill for curing diabetes and its complication | |
| CN101983688B (en) | Drug for treating diabetes and preparation method thereof | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN101396454B (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
| CN1041277C (en) | Quick action injection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |